Product
Donor lymphocyte infusion
1 clinical trial
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
Efficacy and Safety of PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allogeneic Hematopoietic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2024-07-01